Ultratrutide

Description

Ultratrutide – Quad-Agonist Peptide for Metabolic Pathway Investigation Ultratrutide is an experimental quad-agonist peptide engineered for advanced metabolic investigation. It combines the mechanisms of “triple-G” incretins (GLP-1, GIP, and Glucagon) with a Ghrelin receptor agonist. This unique four-way action is designed to study the simultaneous promotion of fat loss and the preservation of lean muscle mass. Overview Ultratrutide represents a significant advancement in peptide architecture, integrating four distinct hormonal pathways into a single compound. While traditional approaches focus on weight reduction via appetite suppression and increased energy expenditure, Ultratrutide introduces a fourth pillar: anabolic support through growth hormone signaling. Mechanisms of Action GLP-1 & GIP: These components work to regulate appetite and improve insulin sensitivity. They provide the foundational model for caloric restriction and glycemic control studies. Glucagon (GCG): Integrated to investigate increased thermogenesis. By signaling the liver to burn stored energy, it targets fat mass reduction pathways. Ghrelin Agonist: The distinguishing feature of Ultratrutide. This component targets the GHS-R1a receptor to stimulate growth hormone release. Investigators utilize this to study the mitigation of muscle wasting (sarcopenia) that typically accompanies rapid metabolic shifts. Investigational Applications The primary objective of Ultratrutide is the study of “Quality of Weight Loss.” Investigators can observe how different systems in the body navigate the conflict between satiety signaling via the GLP-1 and Ghrelin pathways. This makes it an ideal candidate for studies involving insulin sensitivity, metabolic stability, and tissue repair in nutrient-deficit scenarios. Important Notice This product is intended for laboratory investigation and analytical characterization only. Not intended for human or veterinary use.

Research Use Only – Legal Disclaimer

All Eagle Peptides products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind. By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose. Use of these materials is entirely at your own risk. Eagle Peptides assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.